Navigation Links
Silence Therapeutics Signs siRNA Delivery Collaboration With Top 10 Pharma Company
Date:9/26/2011

LONDON, September 27, 2011 /PRNewswire/ --

Silence Therapeutics plc (AIM: SLN) ("Silence"), a leading RNA interference (RNAi) therapeutics company, today announces that it has entered into an agreement with one of the world's leading global pharmaceutical companies to investigate the application of Silence's proprietary DACC delivery technology for intravenous delivery of short interfering RNA sequences ("siRNAs") to the pulmonary vascular endothelium.

Under the terms of the agreement, Silence's partner will provide Silence with specific siRNAs, which Silence will formulate with its DACC delivery system. Silence and its partner will undertake in vitro and in vivo studies of the DACC formulated siRNAs developed under the agreement and select lead candidates for further evaluation. Financial terms were not disclosed.

DACC is a novel lipid delivery system that includes Silence's proprietary lipid AtuFect and is used to embed siRNAs into a multiple lipid bi-layer structure. Whilst closely related to the AtuPLEX™ delivery system used in Atu027, Silence's lead oncology candidate in Phase I trials, DACC has significantly different properties on a physiochemical and pharmacological level. The DACC delivery system is incorporated in Atu111, Silence's preclinical development candidate for the treatment of acute lung injury, and enables functional, highly specific and efficient delivery of RNAi therapeutics to the pulmonary vascular endothelium. In preclinical models, the DACC delivery system has demonstrated highly focused delivery to lung tissue and sustained knockdown of the desired target gene expression in this particular cell type. Of note, the DACC delivery sys
'/>"/>

SOURCE Silence Therapeutics Plc
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Silence Therapeutics Announces Issuance of Japanese Patent for Screening Therapeutics Against Key Pathway Associated with Cancer and Other Diseases
2. Silence Therapeutics and InteRNA Technologies Sign Collaboration to Develop Novel microRNA Therapeutics
3. Silence Therapeutics Receives Notice of Allowance for New U.S. Patent Covering Novel Small Interfering RNA (siRNA) Delivery Technology
4. Silence Therapeutics Phase I Atu027 Data Accepted for Presentation at the American Society of Clinical Oncology 2011 Annual Meeting
5. Silence Therapeutics Issued New U.S. Patent Covering Fundamental RNA Interference Technology Currently in Several Clinical Trials
6. Silence Therapeutics Provides Year-end Update
7. Silence Therapeutics Issued New Patents Covering siRNA Sequences for RNA Interference Therapeutics
8. Silence Therapeutics and AstraZeneca Extend siRNA Development Collaboration
9. Silence Therapeutics to Merge with Intradigm Corp to Create Leading RNAi Therapeutics Company
10. Silence Therapeutics to Receive $1.9m Milestone Payment as Pfizer and Quark Commence Phase II Trial
11. Silence Therapeutics Announces Board Changes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2015)... -- Sequenom, Inc. (NASDAQ: SQNM ), a life sciences ... of innovative products and services, today announced that its ... operations in Grand Rapids, Michigan ... , North Carolina.  Sequenom Laboratories, cystic fibrosis carrier screen ... North Carolina laboratory location.  "The ...
(Date:5/27/2015)... 27, 2015 PharmaPoint: Type 1 Diabetes - Global ... Type 1 diabetes (T1D) is an autoimmune disease that permanently ... the body can no longer produce insulin. Over the last ... present, no other treatment can be offered to a patient ... analogs with different times of action - long-acting as well ...
(Date:5/27/2015)... NEW YORK , May 27, 2015 ... impacted by accelerated aging of population and ... and other lifestyles has been growing year after year, ... (PCI) market. PCI cases in China ... year earlier; meanwhile the interventional cardiovascular device industry there ...
Breaking Medicine Technology:Sequenom Laboratories To Consolidate Michigan And North Carolina Facilities 2Sequenom Laboratories To Consolidate Michigan And North Carolina Facilities 3PharmaPoint: Type 1 Diabetes - Global Drug Forecast and Market Analysis to 2023 2PharmaPoint: Type 1 Diabetes - Global Drug Forecast and Market Analysis to 2023 3PharmaPoint: Type 1 Diabetes - Global Drug Forecast and Market Analysis to 2023 4China Interventional Cardiovascular Device Industry Report, 2014-2017 2China Interventional Cardiovascular Device Industry Report, 2014-2017 3
... Corporation (Nasdaq: THOR ), a world leader in ... failing hearts, said today it will be participating in the ... Wednesday, May 11. David V. Smith, executive vice ... the company, beginning at 8:40 a.m., Pacific Daylight Time (11:40 ...
... CINCINNATI, May 6, 2011 Kendle (Nasdaq: ... today announced the Company is postponing its Annual Meeting ... Research, LLC.  The annual meeting had been scheduled for ... 4, 2011, that it has signed a merger agreement ...
Cached Medicine Technology:Kendle Announces Postponement of 2011 Annual Meeting 2Kendle Announces Postponement of 2011 Annual Meeting 3Kendle Announces Postponement of 2011 Annual Meeting 4
(Date:5/27/2015)... May 27, 2015 While hair transplantation ... loss, a new pilot study conducted by a physician ... (ISHRS) has found hair follicle grafting can help treat ... was partially funded by ISHRS, which offers research grants ... hair restoration. , In the past decade, numerous ...
(Date:5/27/2015)... 27, 2015 The new http://www.carsonenergy.com ... Why investors should consider oil and gas investing, the ... wells are drilled, industry news, IRA investing, definitions and ... years of knowledge and experience is now in one ... to be able to access 24 hours a day, ...
(Date:5/27/2015)... 2015 CURE® Magazine and ... mission is to advance research, provide information and support, ... to battle the fifth most common type of cancer, ... start to grow out of control. , “CURE ... every stage of the cancer experience through digital and ...
(Date:5/27/2015)... 27, 2015 Difass USA, a modern ... U.S. with its first three flagship products, Dormiva™, Relaxiva™ ... nationwide through http://www.difassusa.com . , A restful ... productivity, but some people struggle with getting the full ... a sleep aid designed to help you fall asleep ...
(Date:5/27/2015)... Cincinnati, Ohio (PRWEB) May 27, 2015 Cincinnati ... Education & Research for Veterans (CERV) Foundation is proud to ... information fair for women Veterans June 11 at the Freedom ... Reporter Karin Johnson will be the emcee. , This ... and devotion to the nation. The banquet is free ...
Breaking Medicine News(10 mins):Health News:New Research Finds Hair Grafting a Promising Therapy for Chronic Leg Ulcers - International Society of Hair Restoration Surgery Awards Research Grant 2Health News:New Research Finds Hair Grafting a Promising Therapy for Chronic Leg Ulcers - International Society of Hair Restoration Surgery Awards Research Grant 3Health News:Carson Energy Launches Next Generation Investor Website 2Health News:CURE® Magazine and Bladder Cancer Advocacy Network Align to Increase Awareness of Fifth Most Common Type of Cancer 2Health News:CURE® Magazine and Bladder Cancer Advocacy Network Align to Increase Awareness of Fifth Most Common Type of Cancer 3Health News:Supplement Brand Difass USA Launches in the U.S. with Three Flagship Products Designed to Bring Balance Back to Your Life 2Health News:Cincinnati VA Women’s Health Clinic Celebrates Women Veterans at Awards Banquet 2
... could prevent damage during play, study finds , FRIDAY, ... shoulder strength before the season starts may predict the ... report says. , Such knowledge could help the ... study,s author said. , A five-year study of 144 ...
... asthma, study finds, , THURSDAY, July 9 (HealthDay ... likelihood of developing such allergic disorders as eczema ... findings of 24 studies, researchers from the University ... gene -- which is thought to help maintain ...
... , ... and dc axial fans and blowers are now available in Canada from Electro Sonic. ... Chatsworth, CA (PRWEB) July 10, ... electronic component distributor, announced that they have reached a distribution agreement. Under the ...
... have long plagued the military in part because of ... fracture with microcapsules that deliver a drug to bolster ... , That technology might be around the corner, ... University Department of Orthopaedics and director of the ...
... Medical Equipment, a medical and sports injury supplies company, ... Industry." In a bold move to bring change to ... Precision Durable Medical Equipment, through their website http://www.injurysupplies.com ... acquire the equipment they need through their private insurance, ...
... NEWPORT BEACH, Calif., July 10 Many people struggle with ... can come from bad experiences in the past that they ... they are afraid of losing. The yearning comes from pleasurable ... Unfortunately, what is missing as people bounce back and ...
Cached Medicine News:Health News:Scientists Zero In on Elusive 'Allergy Gene' 2Health News:NMB Expands in Canada 2Health News:Team Develops Anti-Infection Technology 2Health News:Local Company Gives Out Injury Supplies at No Cost to Customers 2Health News:Escape From Fears and Yearnings by Living in the Now 2
... door 4 shelves. Over-sized compressor. ... Fluorescent interior lighting. Self-Contained System No plumbing ... Full One Year Warranty on Parts & ... Compressor. Also available as a chromatography ...
... Independent controls for Digital ... series stainless steel front. Anodized aluminum ends. ... series stainless steel floor. , Oversized ... to -30C , Positive seal self-closing ...
... The HC Series Large Capacity Refigerators ... embryos, semen, or biological samples at liquid-nitrogen ... holding times and capacities are available to ... Two low profile HCL models are also ...
Inquire...
Medicine Products: